Polar Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $10.8M | Sell |
260,703
-734,911
| -74% | -$30.3M | 0.08% | 176 |
|
|
2020
Q2 | $48.3M | Sell |
995,614
-278,752
| -22% | -$13.5M | 0.42% | 76 |
|
|
2020
Q1 | $53.8M | Buy |
1,274,366
+499,988
| +65% | +$21.1M | 0.58% | 50 |
|
|
2019
Q4 | $33.1M | Buy |
+774,378
| New | +$33.1M | 0.29% | 117 |
|
|
2018
Q1 | – | Sell |
-50,000
| Closed | -$1.51M | – | 253 |
|
|
2017
Q4 | $1.51M | Sell |
50,000
-25,000
| -33% | -$753K | 0.02% | 235 |
|
|
2017
Q3 | $2.83M | Sell |
75,000
-100,000
| -57% | -$3.77M | 0.03% | 215 |
|
|
2017
Q2 | $4.88M | Hold |
175,000
| – | – | 0.07% | 189 |
|
|
2017
Q1 | $6.02M | Buy |
175,000
+155,000
| +775% | +$5.33M | 0.09% | 170 |
|
|
2016
Q4 | $577K | Buy |
20,000
+8,750
| +78% | +$252K | 0.01% | 247 |
|
|
2016
Q3 | $358K | Sell |
11,250
-19,143
| -63% | -$609K | 0.01% | 246 |
|
|
2016
Q2 | $987K | Buy |
+30,393
| New | +$987K | 0.02% | 242 |
|
|
2016
Q1 | – | Sell |
-14,595
| Closed | -$520K | – | 262 |
|
|
2015
Q4 | $520K | Sell |
14,595
-6,738
| -32% | -$240K | 0.01% | 248 |
|
|
2015
Q3 | $705K | Sell |
21,333
-9,142
| -30% | -$302K | 0.01% | 250 |
|
|
2015
Q2 | $1.28M | Buy |
30,475
+4,577
| +18% | +$192K | 0.02% | 244 |
|
|
2015
Q1 | $844K | Buy |
25,898
+2,356
| +10% | +$76.8K | 0.02% | 253 |
|
|
2014
Q4 | $747K | Buy |
23,542
+14,933
| +173% | +$474K | 0.01% | 243 |
|
|
2014
Q3 | $213K | Buy |
+8,609
| New | +$213K | ﹤0.01% | 265 |
|